Alliance for Pharmacy Compounding ads

Patients deserve options when standard therapies aren’t enough. That’s where compounding pharmacies step in — making life-changing therapies accessible, affordable, and safe. See how APC is advocating for patient-first policies in our new blog recap of Scott Brunner’s POLITICO Pro Q&A: https://bit.ly/41VbtqA #CompoundingPharmacy #PatientAccess #HealthcarePolicy

Policy debates often focus on intellectual property, but for patients, the real issue is access. Compounding ensures therapies reach the people who need them most, when they need them most. Our blog highlights key takeaways from Scott Brunner’s POLITICO interview— and how APC is driving patient-first policies: https://bit.ly/4pwmt7J #CompoundingPharmacy #AccessToCare #APC

Compounding isn’t competition— it’s a safeguard. By filling gaps left by FDA-approved drugs, compounding supports prescribers and protects patients. Explore APC’s perspective in our latest blog post on Scott Brunner’s POLITICO Pro interview: https://bit.ly/4mrGtpB

Drugmakers have had a lot to say lately about compounded medications, but not all of it true. This week, scores of compounding pharmacists and technicians are on Capitol Hill to meet with members of Congress and share the truth about the essential role compounded drugs play in our healthcare system and the compliance framework within which compounding pharmacies prepare custom medications based on the order of a licensed prescriber. Read more: https://bit.ly/3HZPyYB

The goal of regulation should be better patient outcomes. But many FDA rules and practices affecting compounding do just the opposite. Our Blueprint outlines 14 regulations and practices that compromise care and create unnecessary barriers—without improving safety. Discover how policy reform can restore care options for patients: https://lnkd.in/gqz6nCYz

Overregulation in pharmacy compounding creates confusion, delays care, and undermines access—without improving patient safety. Our Blueprint outlines 14 federal rules and practices that do more harm than good and offers a path toward streamlined, patient-first oversight. See our Blueprint for ensuring patient access to compounded drugs: https://lnkd.in/gqz6nCYz